These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 29278616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
    Sáez-Llorens X, Rowley S, Wong D, Rodríguez M, Calvo A, Troitiño M, Salas A, Vega V, Castrejón MM, Lommel P, Pascal TG, Hausdorff WP, Borys D, Ruiz-Guiñazú J, Ortega-Barría E, Yarzabal JP, Schuerman L.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-16. PubMed ID: 28368738
    [Abstract] [Full Text] [Related]

  • 3. Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.
    Sigurdsson S, Eythorsson E, Hrafnkelsson B, Erlendsdóttir H, Kristinsson KG, Haraldsson Á.
    Clin Infect Dis; 2018 Sep 28; 67(8):1213-1219. PubMed ID: 29617959
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
    Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, Troitiño M, Carabajal C, Falaschi A, Leandro A, Castrejón MM, Lepetic A, Lommel P, Hausdorff WP, Borys D, Ruiz Guiñazú J, Ortega-Barría E, Yarzábal JP, Schuerman L, COMPAS Group.
    PLoS Med; 2014 Jun 28; 11(6):e1001657. PubMed ID: 24892763
    [Abstract] [Full Text] [Related]

  • 5. Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
    Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Borys D, Lommel P, Traskine M, Moreira M, Schuerman L, Kilpi TM.
    Lancet Infect Dis; 2014 Mar 28; 14(3):205-12. PubMed ID: 24287186
    [Abstract] [Full Text] [Related]

  • 6. Prevention of otitis media: now a reality?
    Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R.
    Vaccine; 2009 Sep 25; 27(42):5748-54. PubMed ID: 19666154
    [Abstract] [Full Text] [Related]

  • 7. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
    Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L.
    Vaccine; 2009 Dec 10; 28(1):71-8. PubMed ID: 19818722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland.
    Sveinsdóttir H, Björnsdóttir JB, Erlendsdóttir H, Hjálmarsdóttir MÁ, Hrafnkelsson B, Haraldsson Á, Kristinsson KG, Haraldsson G.
    J Clin Microbiol; 2019 Jul 10; 57(7):. PubMed ID: 31068412
    [Abstract] [Full Text] [Related]

  • 10. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines.
    Ziv O, Kraus M, Holcberg R, Dinur AB, Kordeluk S, Kaplan D, Rosenblatt HN, Ben-Shimol S, Greenberg D, Leibovitz E.
    Int J Pediatr Otorhinolaryngol; 2019 Apr 10; 119():123-130. PubMed ID: 30703661
    [Abstract] [Full Text] [Related]

  • 11. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
    Michel LV, Kaur R, Zavorin M, Pryharski K, Khan MN, LaClair C, O'Neil M, Xu Q, Pichichero ME.
    J Med Microbiol; 2018 Oct 10; 67(10):1527-1532. PubMed ID: 30136923
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.
    Kilpi TM, Jokinen J, Puumalainen T, Nieminen H, Ruokokoski E, Rinta-Kokko H, Traskine M, Lommel P, Moreira M, Ruiz-Guinazu J, Borys D, Schuerman L, Palmu AA.
    Vaccine; 2018 Sep 18; 36(39):5891-5901. PubMed ID: 30145098
    [Abstract] [Full Text] [Related]

  • 13. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
    Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L.
    Lancet; 2006 Mar 04; 367(9512):740-8. PubMed ID: 16517274
    [Abstract] [Full Text] [Related]

  • 14. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P, Black S, Borrow R, Pearce D.
    Clin Ther; 2009 Oct 04; 31(10):2152-69. PubMed ID: 19922887
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
    Ruiz-Palacios GM, Guerrero ML, Hernández-Delgado L, Lavalle-Villalobos A, Casas-Muñoz A, Cervantes-Apolinar Y, Moreira M, Schuerman L.
    Hum Vaccin; 2011 Nov 04; 7(11):1137-45. PubMed ID: 22048109
    [Abstract] [Full Text] [Related]

  • 16. [Acute otitis media in the era of pneumococcal vaccination].
    Baquero-Artigao F, del Castillo F.
    Enferm Infecc Microbiol Clin; 2008 Oct 04; 26(8):505-9. PubMed ID: 19094865
    [Abstract] [Full Text] [Related]

  • 17. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A, Riesbeck K, Janson H.
    Clin Infect Dis; 2008 Mar 01; 46(5):726-31. PubMed ID: 18230042
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
    Vesikari T, Forsten A, Seppä I, Kaijalainen T, Puumalainen T, Soininen A, Traskine M, Lommel P, Schoonbroodt S, Hezareh M, Moreira M, Borys D, Schuerman L.
    J Pediatric Infect Dis Soc; 2016 Sep 01; 5(3):237-248. PubMed ID: 27125273
    [Abstract] [Full Text] [Related]

  • 19. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.
    Pediatrics; 2009 Jun 01; 123(6):1452-63. PubMed ID: 19482754
    [Abstract] [Full Text] [Related]

  • 20. Increase in Haemophilus influenzae Detection in 13-Valent Pneumococcal Conjugate Vaccine Immunized Children With Acute Otitis Media.
    Klein A, Tamir SO, Sorek N, Hanun G, Yeshayahu Y, Marom T.
    Pediatr Infect Dis J; 2022 Aug 01; 41(8):678-680. PubMed ID: 35436266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.